-+ 0.00%
-+ 0.00%
-+ 0.00%

CLEARMIND ACHIEVES FULL ENROLLMENT FOR PART C IN CMND-100 PHASE I/IIA TRIAL, MARKING KEY CLINICAL MILESTONE

Reuters·11/16/2026 12:39:14